Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Binding of CLL subset 4 B-cell receptor immunoglobulins to viable human memory B lymphocytes requires a distinctive IGKV somatic mutation.

Catera R, Liu Y, Gao C, Yan XJ, Magli A, Allen SL, Kolitz JE, Rai KR, Chu CC, Feizi T, Stamatopoulos K, Chiorazzi N.

Mol Med. 2017 Mar;23:1-12. doi: 10.2119/molmed.2017.00003. Epub 2017 Jan 12.


Chronic lymphocytic leukemia immunoglobulins display bacterial reactivity that converges and diverges from auto-/poly-reactivity and IGHV mutation status.

Hatzi K, Catera R, Moreno Atanasio C, Fischetti VA, Allen SL, Kolitz JE, Rai KR, Chu CC, Chiorazzi N.

Clin Immunol. 2016 Nov;172:44-51. doi: 10.1016/j.clim.2016.08.020. Epub 2016 Aug 29.


A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes.

McCarthy BA, Yancopoulos S, Tipping M, Yan XJ, Wang XP, Bennett F, Li W, Lesser M, Paul S, Boyle E, Moreno C, Catera R, Messmer BT, Cutrona G, Ferrarini M, Kolitz JE, Allen SL, Rai KR, Rawstron AC, Chiorazzi N.

Immunol Res. 2015 Dec;63(1-3):90-100. doi: 10.1007/s12026-015-8688-3.


Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability.

Cui X, Zhang L, Magli AR, Catera R, Yan XJ, Griffin DO, Rothstein TL, Barrientos J, Kolitz JE, Allen SL, Rai KR, Chiorazzi N, Chu CC.

Leukemia. 2016 Jan;30(1):74-85. doi: 10.1038/leu.2015.204. Epub 2015 Jul 29.


IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria.

Hwang KK, Trama AM, Kozink DM, Chen X, Wiehe K, Cooper AJ, Xia SM, Wang M, Marshall DJ, Whitesides J, Alam M, Tomaras GD, Allen SL, Rai KR, McKeating J, Catera R, Yan XJ, Chu CC, Kelsoe G, Liao HX, Chiorazzi N, Haynes BF.

PLoS One. 2014 Mar 10;9(3):e90725. doi: 10.1371/journal.pone.0090725. eCollection 2014.


Chronic lymphocytic leukemia monitoring with a Lamprey idiotope-specific antibody.

Nakahara H, Herrin BR, Alder MN, Catera R, Yan XJ, Chiorazzi N, Cooper MD.

Cancer Immunol Res. 2013 Oct;1(4):223-8. doi: 10.1158/2326-6066.CIR-13-0052.


Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells.

Hwang KK, Chen X, Kozink DM, Gustilo M, Marshall DJ, Whitesides JF, Liao HX, Catera R, Chu CC, Yan XJ, Luftig MA, Haynes BF, Chiorazzi N.

Blood. 2012 Feb 16;119(7):e35-44. doi: 10.1182/blood-2011-08-371203. Epub 2011 Dec 12.


Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.

Chu CC, Catera R, Zhang L, Didier S, Agagnina BM, Damle RN, Kaufman MS, Kolitz JE, Allen SL, Rai KR, Chiorazzi N.

Blood. 2010 May 13;115(19):3907-15. doi: 10.1182/blood-2009-09-244251. Epub 2010 Jan 28.


Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.

Seiler T, Woelfle M, Yancopoulos S, Catera R, Li W, Hatzi K, Moreno C, Torres M, Paul S, Dohner H, Stilgenbauer S, Kaufman MS, Kolitz JE, Allen SL, Rai KR, Chu CC, Chiorazzi N.

Blood. 2009 Oct 22;114(17):3615-24. doi: 10.1182/blood-2009-01-197822. Epub 2009 Aug 18.


Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation.

Catera R, Silverman GJ, Hatzi K, Seiler T, Didier S, Zhang L, Hervé M, Meffre E, Oscier DG, Vlassara H, Scofield RH, Chen Y, Allen SL, Kolitz J, Rai KR, Chu CC, Chiorazzi N.

Mol Med. 2008 Nov-Dec;14(11-12):665-74. doi: 10.2119/2008-00102.Catera. Epub 2008 Sep 25.


Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.

Chu CC, Catera R, Hatzi K, Yan XJ, Zhang L, Wang XB, Fales HM, Allen SL, Kolitz JE, Rai KR, Chiorazzi N.

Blood. 2008 Dec 15;112(13):5122-9. doi: 10.1182/blood-2008-06-162024. Epub 2008 Sep 23.


Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18).

McCarthy BA, Boyle E, Wang XP, Guzowski D, Paul S, Catera R, Trott J, Yan XJ, Croce CM, Damle R, Yancopoulos S, Messmer BT, Lesser M, Allen SL, Rai KR, Chiorazzi N.

Mol Med. 2008 Sep-Oct;14(9-10):618-27. doi: 10.2119/2008.00061.McCarthy.

Supplemental Content

Loading ...
Support Center